PLoS ONE (Jan 2017)
Correction: Novel Synthetic Oxazines Target NF-κB in Colon Cancer In Vitro and Inflammatory Bowel Disease In Vivo.
Abstract
[This corrects the article DOI: 10.1371/journal.pone.0163209.].
PLoS ONE (Jan 2017)
[This corrects the article DOI: 10.1371/journal.pone.0163209.].